Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Solriamfetol may be useful for adults experiencing eating disorders.
What would participation involve?
Participants may receive Solriamfetol, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.
Who is it mainly for?
This study appears to be mainly for adults with eating disorders.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: February 20, 2025
Recruitment status
Enrolling By Invitation
Enrollment listed in the registry
236
Sponsor
Axsome Therapeutics, Inc.
Sponsor type
Biotech company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 56 Years
Official registry ID
NCT06878976
Official title
An Open-Label and Double-Blind, Randomized Withdrawal Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Adults With Binge Eating Disorder
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT06878976. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
United States · 33 sites
Clinical Research Site
Encino, California
Site status: Not listed — confirm with the team
Clinical Research Site
Long Beach, California
Site status: Not listed — confirm with the team
Clinical Research Site
Santa Ana, California
Site status: Not listed — confirm with the team
Clinical Research Site
Walnut Creek, California
Site status: Not listed — confirm with the team
Clinical Research Site
West Covina, California
Site status: Not listed — confirm with the team
Clinical Research Site
Cromwell, Connecticut
Site status: Not listed — confirm with the team
Clinical Research Site
Fort Myers, Florida
Site status: Not listed — confirm with the team
Clinical Research Site
Jacksonville, Florida
Site status: Not listed — confirm with the team
Clinical Research Site
Lauderhill, Florida
Site status: Not listed — confirm with the team
Clinical Research Site
Miami, Florida
Site status: Not listed — confirm with the team
Clinical Research Site
Miami, Florida
Site status: Not listed — confirm with the team
Clinical Research Site
Miami Lakes, Florida
Site status: Not listed — confirm with the team
Clinical Research Site
Orlando, Florida
Site status: Not listed — confirm with the team
Clinical Research Site
Marietta, Georgia
Site status: Not listed — confirm with the team
Clinical Research Site
Overland Park, Kansas
Site status: Not listed — confirm with the team
Clinical Research Site
Boston, Massachusetts
Site status: Not listed — confirm with the team
Clinical Research Site
Saint Charles, Missouri
Site status: Not listed — confirm with the team
Clinical Research Site
Cherry Hill, New Jersey
Site status: Not listed — confirm with the team
Clinical Research Site
Mount Kisco, New York
Site status: Not listed — confirm with the team
Clinical Research Site
New York, New York
Site status: Not listed — confirm with the team
Clinical Research Site
Raleigh, North Carolina
Site status: Not listed — confirm with the team
Clinical Research Site
Cincinnati, Ohio
Site status: Not listed — confirm with the team
Clinical Research Site
Mason, Ohio
Site status: Not listed — confirm with the team
Clinical Research Site
Middleburg Heights, Ohio
Site status: Not listed — confirm with the team
Clinical Research Site
North Canton, Ohio
Site status: Not listed — confirm with the team
Clinical Research Site
Portland, Oregon
Site status: Not listed — confirm with the team
Clinical Research Site
Allentown, Pennsylvania
Site status: Not listed — confirm with the team
Clinical Research Site
North Charleston, South Carolina
Site status: Not listed — confirm with the team
Clinical Research Site
Memphis, Tennessee
Site status: Not listed — confirm with the team
Clinical Research Site
Austin, Texas
Site status: Not listed — confirm with the team
Clinical Research Site
Austin, Texas
Site status: Not listed — confirm with the team
Clinical Research Site
Dallas, Texas
Site status: Not listed — confirm with the team
Clinical Research Site
San Antonio, Texas
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with eating disorders. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Solriamfetol, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with eating disorders; age range: From 18 Years to 56 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Axsome Therapeutics, Inc., which appears to be a biotech company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists enrollment by invitation. This is not open recruitment; contact the research team to understand who may be invited.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
